These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22791802)

  • 1. Effect of the carrier solution for hydroxyethyl starch on platelet aggregation and clot formation.
    Schaden E; Wetzel L; Kozek-Langenecker S; Thaler U; Scharbert G
    Br J Anaesth; 2012 Oct; 109(4):572-7. PubMed ID: 22791802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new plasma-adapted hydroxyethyl starch preparation: in vitro coagulation studies.
    Boldt J; Mengistu A
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):394-8. PubMed ID: 20005132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of a balanced crystalloid-based and a saline-based tetrastarch solution on canine whole blood coagulation and platelet function.
    Reuteler A; Axiak-Flammer S; Howard J; Adamik KN
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):23-34. PubMed ID: 27926787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy.
    Boldt J; Suttner S; Brosch C; Lehmann A; Röhm K; Mengistu A
    Anesth Analg; 2009 Dec; 109(6):1752-62. PubMed ID: 19923501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the in vitro effects of saline, hypertonic hydroxyethyl starch, hypertonic saline, and two forms of hydroxyethyl starch on whole blood coagulation and platelet function in dogs.
    Wurlod VA; Howard J; Francey T; Schweighauser A; Adamik KN
    J Vet Emerg Crit Care (San Antonio); 2015; 25(4):474-87. PubMed ID: 26037241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects on coagulation of balanced (130/0.42) and non-balanced (130/0.4) hydroxyethyl starch or gelatin compared with balanced Ringer's solution: an in vitro study using two different viscoelastic coagulation tests ROTEMTM and SONOCLOTTM.
    Casutt M; Kristoffy A; Schuepfer G; Spahn DR; Konrad C
    Br J Anaesth; 2010 Sep; 105(3):273-81. PubMed ID: 20659913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of haemodilution with hydroxyethyl starch 130/0.4 solution on coagulation as assessed by thromboelastography and platelet receptor function studies in vitro.
    Williams P; Yang K; Kershaw G; Wong G; Dunkley S; Kam PC
    Anaesth Intensive Care; 2015 Nov; 43(6):734-9. PubMed ID: 26603798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation.
    Ruttmann TG; James MF; Aronson I
    Br J Anaesth; 1998 May; 80(5):612-6. PubMed ID: 9691864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography.
    Jamnicki M; Zollinger A; Seifert B; Popovic D; Pasch T; Spahn DR
    Anesth Analg; 1998 Nov; 87(5):989-93. PubMed ID: 9806670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence on coagulation of a potato-derived hydroxethylstarch (HES 130/0.42) and a maize-derived hydroxethylstarch (HES 130/0.4) in patients undergoing cardiac surgery.
    Boldt J; Suttner S; Brosch C; Lehmann A; Mengistu A
    Br J Anaesth; 2009 Feb; 102(2):191-7. PubMed ID: 19074154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose of hydroxyethyl starch impairs clot formation as assessed by viscoelastic devices.
    Tynngård N; Berlin G; Samuelsson A; Berg S
    Scand J Clin Lab Invest; 2014 Jun; 74(4):344-50. PubMed ID: 24621204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hydroxyethyl starch on platelet aggregation in vitro.
    Blaicher AM; Reiter WJ; Blaicher W; Kettner SC; Felfernig M; Grabner CM; Zimpfer M
    Anesth Analg; 1998 Jun; 86(6):1318-21. PubMed ID: 9620527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation.
    Jamnicki M; Bombeli T; Seifert B; Zollinger A; Camenzind V; Pasch T; Spahn DR
    Anesthesiology; 2000 Nov; 93(5):1231-7. PubMed ID: 11046211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation, oncotic and haemodilutional effects of a third-generation hydroxyethyl starch (130/0.4) solution in horses.
    Viljoen A; Page PC; Fosgate GT; Saulez MN
    Equine Vet J; 2014 Nov; 46(6):739-44. PubMed ID: 24372968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
    Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR
    Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight.
    Entholzner EK; Mielke LL; Calatzis AN; Feyh J; Hipp R; Hargasser SR
    Acta Anaesthesiol Scand; 2000 Oct; 44(9):1116-21. PubMed ID: 11028733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypertonic saline hydroxyethyl starch solution on collagen-induced platelet aggregation and ATP secretion.
    Scherer R; Giebler R; Kampe S; Kox WJ
    Infusionsther Transfusionsmed; 1994 Oct; 21(5):310-4. PubMed ID: 7528584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro impairment of whole blood coagulation and platelet function by hypertonic saline hydroxyethyl starch.
    Hanke AA; Maschler S; Schöchl H; Flöricke F; Görlinger K; Zanger K; Kienbaum P
    Scand J Trauma Resusc Emerg Med; 2011 Feb; 19():12. PubMed ID: 21310047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro comparison of the effects of voluven (6% hydroxyethyl starch 130/0.4) and hespan (6% hydroxyethyl starch 670/0.75) on measures of blood coagulation in canine blood.
    Griego-Valles M; Buriko Y; Prittie JE; Fox PR
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):44-51. PubMed ID: 27712013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is dilutional coagulopathy induced by different colloids reversible by replacement of fibrinogen and factor XIII concentrates?
    Kind SL; Spahn-Nett GH; Emmert MY; Eismon J; Seifert B; Spahn DR; Theusinger OM
    Anesth Analg; 2013 Nov; 117(5):1063-71. PubMed ID: 24029856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.